Fixed-dose combination pen containing both cagrilintide and semaglutide
As a GLP-1/GIP receptor agonist , Zepbound affects the digestive system
Endocrinol Nutr 59(3):197206 Devoto F, Zapparoli L, Bonandrini R, Berlingeri M, Ferrulli A, Luzi L et al (2018) Hungry brains: a meta-analytical review of brain activation imaging studies on food perception and appetite in obese individuals
Other groups requiring careful evaluation include: Patients with a history of pancreatitis a causal relationship between incretin-based therapies and pancreatitis has not been definitively established, but UK SmPCs advise caution in those with a prior history
Many doctors, including Francavilla, advise restarting at the lowest dose, as jumping back to your previous dose can cause more severe side effects, like nausea and vomiting
At 5 mg/mL, 1 mg = 0.20 mL = 20 units